Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Follow the SBFM COVID pill study progression in the PRs (see link below). April 19th, June 9th, August 12th. I agree NEWS is due soon!
https://sunshinebiopharma.com/press-release-archives/
I don't think gone forever, but maybe for a few more years. It's pretty much been gone since 2016 with a lot of false promises and false hopes between then and now.
I also read the lawsuit JBS filed against Scout Security related to not being able to sale his shares in that company. Trying to sell his shares was tied to needing the money for his medical bills. Not sure if the medical issues are related to why nothing happened here at ADTM, but interesting background information nonetheless.
A GREEN DAY in SUNSHINEVILLE! The happy weekend has begun! Looking forward to more GREEN DAYS ahead.
More specifically from his profile:
Experience
Gas Management LLC
Co-Founder
Gas Management LLC
Jul 2021 - Present, 4 months
Oklahoma City, Oklahoma, United States
Devvio Inc
Member Of The Board Of Advisors
Devvio Inc
Jan 2020 - Present, 1 year 10 months
Albuquerque, New Mexico, United States
From JBS's LinkedIn profile: https://www.linkedin.com/in/johnbstrong
Hopefully excellently! COVID, CANCER & NEURO DISEASES
And here is the corporate entity information:
https://www.sos.ok.gov/corp/corpInformation.aspx?id=3512923124
This is a website for Jordan Williamson's Gas Analytics business. Jordan Williamson is the Registered Agent for Gas Management, LLC supposedly co-founded by JBS. What do they have planned?
https://gasinc.us/
I may hold what I have left until 2025! That will be about 9 years since my first purchase.
I was thinking of a tax loss this year, but with all the hopefulness on this board that JBS will still pull something out of his ADTM hat, I may just have to stick it out a few more years!
Any progress on ADTM linking up with DEVVIO and/or GAS MANAGMENT LLC?
Here's the Press Release about the UGA Licensing Agreement:
https://sunshinebiopharma.com/assets/press/Press%20Release_Wins%20Exclusive%20License_202102xx_V3.pdf
Yes, perhaps still involved although from the below information in the August press release the licensing is with UGA so whether or not Scott Pagan is still involved may not matter as long as SBFM still has this licensing agreement with UGA and they are still working on all three compounds.
"On February 1, 2021, Sunshine Biopharma entered into an exclusive
license agreement with the University of Georgia for two Anti-Coronavirus compounds which the University of Georgia had previously developed and patented. The Company is currently advancing the development of these two compounds in parallel with its own SBFM-PL4 by conducting a transgenic mice study in collaboration with the University of Georgia, College of
Pharmacy."
Is Scott Pagan still involved with SBFM if he left UGA?
Thanks. Hopefully SBFM preclinical antiviral drug and/or the cancer drug results are released sometime this year and leading into 2022.
More news and updates on their neurodegenerative treatment progress will be icing on the cake.
Any thoughts on the new guy (Chad Brown) at AEGIS and how he might help SBFM make some progress before they get to the NASDAQ.
I found this: http://sdvoyager.com/interview/meet-chad-brown-rg-bar-investment-group-del-mar-heights/
Did you say no names with this company on the website? I see several names and bios at this link: https://exxegroup.com/management-team/
The new website is better than the one they had for the last 2 years! I didn't find much useful on the last one. This one provides more information. We'll see where it goes from here, but maybe they will have a better website 2 years from now for anyone here now that follows AXXA that long. For me, I'm in for a least 6 more months to see how the first part of 2022 turns out (for better or for worse)!
Sounds good. Speculation range is now $.05-$.20. Anywhere in between would be great!
Based on post #93848, but I don't think CCAJ will go directly to "silver" but instead make a pit stop in the $.02 range, then the $.03 range before heading to $.05.
In another previous post (by another poster) there was an estimate that CCAJ would hit $.12, but logic says CCAJ would have to get through $.02, $.03, $.05 etc. before it can get to $.12.
This is all based on speculation, but a few other posters are speculating much higher then where CCAJ sits today.
Looking forward to $.02, $.03 then $.05!
I'd like to see more frequent updates on the SBFM Triad: COVID Pill, Cancer treatment and soon to be neurodegeneration treatment. Even if the neurodegeneration treatment development takes a year to make some good progress, I can hold for that! Let's see where mRNA takes SBFM in the coming 6-12 months.
From SFBM CEO: “We are excited about this discovery for patients suffering from neurodegenerative disorders. Our possible mRNA treatment could arrest progression of neurodegeneration, alleviate symptoms, relieve pain, and increase mobility,”
Didn't make it back to $.02 this week, but looking forward to the next leg up in the not too distant future!
Based on this post a few weeks ago:
twitums Friday, 09/03/21 04:07:27 PM
Post #93641 of 93842
Followers: 343
Watch out when the next report comes out-be prepared to see 12 cents or higher.
------------------------------------------------------
I don't know about 12 cents, but maybe 5 cents in 2021!
I'm getting ready for another run to $.02+ and then $.03! Even if it takes a couple weeks! Maybe $.05+ by the end of the year!
Agree on the variability of information even when we look back years from now on this pandemic and how it ultimately unfolds. Ultimately it will likely be a combination of natural immunity, vaccine immunity and treatment.
Agree, so SBFM needs to get Cancer treatment on a "faster" track. Seems slow right now even though it takes a long time to develop effective medications. Hopefully the Aegis funding catapults SBFM over any current funding obstacles!
From what I've heard and read, the death rate is higher in non-vaccinated who get COVID, but we'll have to see what history says about that. I also think both vaccine and treatment are the long-term solutions so SBFM needs to get their pill to market! I'm assuming they are still actively working on the pill despite the competition (MERCK). Just waiting for SBFM News to update the progress.
AXXA back to $.10 on 1MYLE news? That would definitely make up for all the lower days we have had recently!
Is CCAJ sneaking back up to $.02 in the week ahead?
How about $3/share pre-split, then a 1 for 2 RS resulting in $6/share post-split, then grow to $10/share and a NAS listing! What would it take for the 1st part? A bunch of excellent news about COVID and CANCER treatment success and getting on the FDA fast-track.
Excellent SBFM forecast! The highs and precipitation $$$ this week should lead to a lot of extra sunshine $$$ next week. The long-term forecast should lead to higher highs and more sunshine $$$ in the coming weeks!
What is the forecast for SBFM this week?
What is the forecast for AXXA this week?
What is the forecast for CCAJ this week?
Sounds good. Let's see where CCAJ lands $.05-.20+
Looking forward to $.05+ in days/weeks!
Because they have been working on Cancer for a lot longer. However, I think we are splitting hairs here....I was just highlighting that COVID treatment is a major focus of SBFM now in addition to their longer-term focus on Cancer. I also forgot to mention in my original post that they are also focused on nutrition (perhaps the real ratio of their focus is 50% Cancer, 40% COVID and 10% Nutrition).
Seems like consolidation around $.02 within days and then $.05-.12 within weeks.
It means the AS and OS have been verified by the Transfer Agent as of that date. That is one piece of being current, but they need to file quarterly/annual reports. Why JBS hasn't done that is the question. If I recall correctly that was his intention back in 2018, but never followed through.